Dagher, H.; Hachem, R.; Chaftari, A.-M.; Jiang, Y.; Ali, S.; Deeba, R.; Shah, S.; Raad, I.
Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. J. Fungi 2022, 8, 74.
https://doi.org/10.3390/jof8010074
AMA Style
Dagher H, Hachem R, Chaftari A-M, Jiang Y, Ali S, Deeba R, Shah S, Raad I.
Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. Journal of Fungi. 2022; 8(1):74.
https://doi.org/10.3390/jof8010074
Chicago/Turabian Style
Dagher, Hiba, Ray Hachem, Anne-Marie Chaftari, Ying Jiang, Shahnoor Ali, Rita Deeba, Shivan Shah, and Issam Raad.
2022. "Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant" Journal of Fungi 8, no. 1: 74.
https://doi.org/10.3390/jof8010074
APA Style
Dagher, H., Hachem, R., Chaftari, A.-M., Jiang, Y., Ali, S., Deeba, R., Shah, S., & Raad, I.
(2022). Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. Journal of Fungi, 8(1), 74.
https://doi.org/10.3390/jof8010074
